Antitumor Activity and Safety of Enzalutamide After Abiraterone Acetate: Seeking the Optimal Treatment Sequence for Castration-resistant Prostate Cancer Patients

Cost Effectiveness of Abiraterone Acetate Plus Prednisone in the Pre-Chemotherapy Setting Followed by Enzalutamide in the Post-Chemotherapy Setting Versus the Opposite Treatment Sequence in Metastatic Castration-Resistant Prostate Cancer Patients Under the Brazilian Private Health Care System Perspective

Value in Health ◽

10.1016/j.jval.2016.03.1584 ◽

2016 ◽

Vol 19 (3) ◽

pp. A149 ◽

Cited By ~ 1

Author(s):

L Pititto ◽

E Asano

Keyword(s):

Prostate Cancer ◽

Health Care ◽

Cost Effectiveness ◽

Cancer Patients ◽

Abiraterone Acetate ◽

Treatment Sequence ◽

Private Health Care ◽

System Perspective ◽

Cost Treatment Comparison of Abiraterone Acetate Plus Prednisone in the Pre-Chemotherapy Setting Followed by Enzalutamide in the Post-Chemotherapy Setting Versus the Opposite Treatment Sequence in Metastatic Castration-Resistant Prostate Cancer Patients With Non-Visceral Metastases in Peru

Value in Health ◽

10.1016/j.jval.2018.04.152 ◽

2018 ◽

Vol 21 ◽

pp. S24

Author(s):

J De La Cruz-Vargas ◽

N Chavez-Villanueva ◽

E Guerrero ◽

A Aguirre ◽

G Ojeda-Botteri

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Abiraterone Acetate ◽

Treatment Sequence ◽

Treatment Comparison ◽

Castration Resistant ◽

Cost Treatment ◽

Visceral Metastases

Budget Impact Comparison of Abiraterone Acetate Plus Prednisone in the Pre-Chemotherapy Setting Followed by Enzalutamide in the Post-Chemotherapy Setting Versus the Opposite Treatment Sequence in Metastatic Castration-Resistant Prostate Cancer Patients Under the Brazilian Private Health Care System Perspective

Value in Health ◽

10.1016/j.jval.2016.03.1549 ◽

2016 ◽

Vol 19 (3) ◽

pp. A142

Author(s):

L Pititto ◽

E Asano

Keyword(s):

Prostate Cancer ◽

Health Care ◽

Cancer Patients ◽

Budget Impact ◽

Abiraterone Acetate ◽

Treatment Sequence ◽

Private Health Care ◽

System Perspective ◽

A Cost Comparison of Treatment with Abiraterone Acetate Plus Prednisone in the Pre Chemotherapy Setting Followed By Enzalutamide in the Post-Chemotherapy Setting Versus the Opposite Treatment Sequence in Metastatic Castration Resistant Prostate Cancer Patients With non-Visceral Metastases

Value in Health ◽

10.1016/j.jval.2015.09.1109 ◽

2015 ◽

Vol 18 (7) ◽

pp. A446

Author(s):

L Dearden ◽

I Girod ◽

I Majer ◽

G van de Wetering

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Abiraterone Acetate ◽

Cost Comparison ◽

Treatment Sequence ◽

Castration Resistant ◽

Visceral Metastases

Finding the optimal treatment sequence in metastatic castration-resistant prostate cancer—a narrative review

Translational Andrology and Urology ◽

10.21037/tau-20-1341 ◽

2021 ◽

Vol 0 (0) ◽

pp. 0-0

Author(s):

Corinne Maurice Dror ◽

Kim N. Chi ◽

Daniel J. Khalaf

Keyword(s):

Prostate Cancer ◽

Optimal Treatment ◽

Narrative Review ◽

Treatment Sequence ◽

713 ABIRATERONE ACETATE IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS WITHOUT PRIOR CHEMOTHERAPY - INTERIM ANALYSIS OF THE COU-AA-302 PHASE 3 TRIAL

The Journal of Urology ◽

10.1016/j.juro.2013.02.272 ◽

2013 ◽

Vol 189 (4S) ◽

Cited By ~ 1

Author(s):

Fred Saad ◽

Neal D Shore ◽

Hendrik Van Poppel ◽

Dana Rathkopf ◽

Matthew R. Smith ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Interim Analysis ◽

Abiraterone Acetate ◽

Phase 3 ◽

Prior Chemotherapy ◽

Enzalutamide in Combination with Abiraterone Acetate in Bone Metastatic Castration-resistant Prostate Cancer Patients

European Urology Oncology ◽

10.1016/j.euo.2019.01.008 ◽

2020 ◽

Vol 3 (1) ◽

pp. 119-127 ◽

Cited By ~ 2

Author(s):

Eleni Efstathiou ◽

Mark Titus ◽

Sijin Wen ◽

Patricia Troncoso ◽

Anh Hoang ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Abiraterone Acetate ◽

Charting Recent Progress and Challenges in Metastatic Castration-resistant Prostate Cancer: Is There an Optimal Treatment Sequence?

European Urology Focus ◽

10.1016/j.euf.2015.11.008 ◽

2016 ◽

Vol 2 (4) ◽

pp. 426-440 ◽

Cited By ~ 3

Author(s):

Stéphane Oudard ◽

Pablo Maroto ◽

Gaston Demonty ◽

Winald R. Gerritsen

Keyword(s):

Prostate Cancer ◽

Recent Progress ◽

Optimal Treatment ◽

Treatment Sequence ◽

Budget Impact Analysis of Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer Patients Previously Treated with Docetaxel from the Perspective of the Brazilian Private Health Care System

Value in Health ◽

10.1016/j.jval.2013.08.1908 ◽

2013 ◽

Vol 16 (7) ◽

pp. A665 ◽

Cited By ~ 1

Author(s):

V. Vitale ◽

E. Asano ◽

M.L. Pereira

Keyword(s):

Prostate Cancer ◽

Health Care ◽

Cancer Patients ◽

Impact Analysis ◽

Budget Impact ◽

Abiraterone Acetate ◽

Private Health Care ◽

Castration Resistant ◽

Previously Treated

Effectiveness of Deferred Combined Androgen Blockade Therapy Predicts Efficacy in Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer Patients after Docetaxel

Frontiers in Pharmacology ◽

10.3389/fphar.2017.00836 ◽

2017 ◽

Vol 8 ◽

Author(s):

Jian-Ri Li ◽

Kun-Yuan Chiu ◽

Shian-Shiang Wang ◽

Cheng-Kuang Yang ◽

Chuan-Shu Chen ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Abiraterone Acetate ◽

Combined Androgen Blockade ◽

Castration Resistant ◽

Androgen Blockade